Abiopharma

KULR Technology Group Appoints New Chief Financial Officer and Independent Board Member

Bed Bath & Beyond Expands Home Services Pillar Through Acquisition of Installed Right and SFV Services

Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium

Ernexa Therapeutics Highlights Ovarian Cancer Unmet Need, Hope for Patients and Potential Accessibility Advantages of ERNA-101 in Virtual Investor KOL Connect Segment Featuring Dr. Ira Winer

General Announcement: Further Partial Hedging of Divestment Consideration

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Changes in Interest of Director - Koh Wee Seng

Duos Edge AI to Host Hereford Edge Data Center Open House

Clinical trial NCT06680830 updates: 1. completion date: 2027-09-01 → 2028-06-01 2. primary completion date: 2026-09-01 → 2027-12-01

Clinical trial NCT07633301: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT06029439: status: RECRUITING → ACTIVE_NOT_RECRUITING.